Skip to main content

Advertisement

Articles

Page 4 of 7

  1. The increasing prevalence of chronic diseases puts a high burden on the health care systems of Low and Middle Income Countries which are often not adapted to provide the care needed. Peer support programmes ar...

    Authors: Josefien van Olmen, Natalie Eggermont, Maurits van Pelt, Heang Hen, Jeroen de Man, François Schellevis, David H. Peters and Maryam Bigdeli

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:1

    Content type: Research

    Published on:

  2. Authors: Edmund Rutta, Jafary Liana, Martha Embrey, Keith Johnson, Suleiman Kimatta, Richard Valimba, Rachel Lieber, Elizabeth Shekalaghe and Hiiti Sillo

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:29

    Content type: Erratum

    Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2015 8:23

  3. The Nigerian health sector battles with control of infectious diseases and emerging non-communicable diseases. Number of healthcare personnel involved in public health programs need to be boosted to contain th...

    Authors: Ogochukwu Offu, Maureen Anetoh, Matthew Okonta and Obinna Ekwunife

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:27

    Content type: Research

    Published on:

  4. The irrational use of reserved antimicrobials, such as ceftriaxone, is one of the global public health issues particularly to low income countries like Ethiopia, leading to high costs of treatment or therapeut...

    Authors: Tariku Shimels, Arebu I Bilal and Anwar Mulugeta

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:26

    Content type: Research

    Published on:

  5. Some humanitarian and development organizations respond to major natural disasters and emergencies by donating medicines. Many provide medicines on a routine basis to support health systems, particularly those...

    Authors: Nuria Cañigueral-Vila, Jennifer C. Chen, Lindsey Frenkel-Rorden and Richard Laing

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:28

    Content type: Review

    Published on:

  6. Withdrawal of conditional regulatory approval or subsidization of new medicines when subsequent evidence does not confirm early trial results may not be well understood or accepted by the public.

    Authors: Agnes Vitry, Tuan Nguyen, Vikky Entwistle and Elizabeth Roughead

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:25

    Content type: Research

    Published on:

  7. Hypertension is the leading modifiable cause of mortality worldwide. Unlike many conditions where limited evidence exists for management of older individuals, multiple large, robust trials have provided a soli...

    Authors: Tariq M Alhawassi, Ines Krass and Lisa G Pont

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:24

    Content type: Review

    Published on:

  8. Authors: Roberta Joppi, Elisa Cinconze, Luca Demattè, Renato Guseo, Claudio Jommi, Cinzia Mortarino, Daniela Pase, Chiara Poggiani, Alessandro Roggeri and Daniela Roggeri

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P9

    Content type: Poster presentation

    Published on:

    This article is part of a Supplement: Volume 8 Supplement 1

Annual Journal Metrics

Advertisement